Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
54.40
+1.53 (2.89%)
May 16, 2025, 3:00 PM CST
Jiangsu Sinopep-Allsino Biopharmaceutical Company Description
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, sale, and technical service of peptides and small molecule drugs in China.
The company offers APIs, including peptides, small molecules, and oligonucleotides; and intermediate products, such as fulvestrant, oseltamivir, and other intermediates.
It also provides CRDMO/CMO services. The company was founded in 2009 and is headquartered in Hangzhou City, China.
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Country | China |
Founded | 2009 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 1,545 |
CEO | Ziquan Tong |
Contact Details
Address: Building E Hangzhou City, 311121 China | |
Phone | 86 571 8867 1216 |
Website | sinopep.com |
Stock Details
Ticker Symbol | 688076 |
Exchange | Shanghai Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | CNY |
ISIN Number | CNE1000051X5 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Wei Ding | Financial Director |
Zhou Hua | Secretary of Board |
Dr. Jianjun Jiang Ph.D. | Deputy General Manager |
Xiaohua Li | Deputy General Manager |